Skip to content
-
Subscribe to our newsletter & never miss our best posts. Subscribe Now!
Itfy.in

At Itfy, we are dedicated to revolutionizing the way you receive news. Our mission is to provide timely, accurate, and personalized news updates using cutting-edge AI technology. Stay informed, stay ahead with us.

Itfy.in

At Itfy, we are dedicated to revolutionizing the way you receive news. Our mission is to provide timely, accurate, and personalized news updates using cutting-edge AI technology. Stay informed, stay ahead with us.

  • Home
  • News Updates
    • Latest News
    • Entertainment News
    • Northeast News
  • Technology
    • Digital Transformation
    • Artificial Intelligence
    • Machine Learning
    • Generative AI
    • Cybersecurity
  • Education & Growth
    • Education
    • Lifelong Learning
    • Parenting
    • Career Growth
  • Startup & Entrepreneurship
    • Remote Work
    • Startups
    • Digital Marketing
    • Social Media
    • Entrepreneurship
    • Lean Thinking
    • Personal Finance
  • Climate Justice
    • Climate Tech
  • Health & Wellness
    • Mental Health
  • Tourism
  • Home
  • News Updates
    • Latest News
    • Entertainment News
    • Northeast News
  • Technology
    • Digital Transformation
    • Artificial Intelligence
    • Machine Learning
    • Generative AI
    • Cybersecurity
  • Education & Growth
    • Education
    • Lifelong Learning
    • Parenting
    • Career Growth
  • Startup & Entrepreneurship
    • Remote Work
    • Startups
    • Digital Marketing
    • Social Media
    • Entrepreneurship
    • Lean Thinking
    • Personal Finance
  • Climate Justice
    • Climate Tech
  • Health & Wellness
    • Mental Health
  • Tourism
Close

Search

  • https://www.facebook.com/
  • https://twitter.com/
  • https://t.me/
  • https://www.instagram.com/
  • https://youtube.com/
Subscribe
Home/News/Breakthrough Triumph: Enteromix’s Cancer Vaccine Achieves 100% Efficacy in Clinical Trials, Offering Hope to Patients
News

Breakthrough Triumph: Enteromix’s Cancer Vaccine Achieves 100% Efficacy in Clinical Trials, Offering Hope to Patients

By adminitfy
September 7, 2025 2 Min Read

In a groundbreaking development that could revolutionize cancer treatment, Russia’s mRNA-based vaccine, Enteromix, has demonstrated a remarkable 100% efficacy and safety during clinical trials. Designed to specifically target and eradicate cancer cells while effectively shrinking larger tumors, Enteromix is awaiting final approval from the Ministry of Health before it becomes available to the public, according to RT India.

Developed through advanced technology akin to that used in COVID-19 vaccines, Enteromix works by training the immune system to identify and destroy cancer cells. Each dose is personalized for individual patients, potentially marking a significant shift toward tailored cancer therapies. Unlike traditional chemotherapy and radiation treatments, which often come with severe side effects, patients have reportedly tolerated Enteromix exceptionally well, showing no serious adverse reactions.

The clinical trials, which reported their promising results earlier this year, included 48 volunteers and were conducted by the National Medical Research Radiology Centre in partnership with the Engelhardt Institute of Molecular Biology of the Russian Academy of Sciences. The initiative was announced during the St. Petersburg International Economic Forum (SPIEF 2025), an event showcasing Russia’s advancements in medicine and biotechnology.

According to MedPath, Enteromix utilizes four benign viruses to attack and eliminate malignant tumors while bolstering the immune response against cancer. After several years of research and testing, the vaccine has not only shown effectiveness in inhibiting tumor growth but has also succeeded in completely eliminating cancer in specific cases.

With the clinical trials completed, the final hurdle for Enteromix is regulatory approval. If granted, this vaccine could set a historic precedent as the first personalized mRNA cancer vaccine to hit the market, potentially saving thousands of lives worldwide.

As healthcare continues to evolve with innovative treatments, Enteromix stands out as a beacon of hope in the fight against cancer, promising a future where personalized medicine paves the way for improved survival rates and quality of life for patients globally. The scientific community and patients alike are waiting with bated breath for the green light that could bring this revolutionary treatment within reach.

Original Source: https://timesofindia.indiatimes.com/life-style/health-fitness/health-news/enteromix-russias-cancer-vaccine-achieves-100-efficacy-in-clinical-trials/articleshow/123749347.cms
Category :
Tags:
Publish Date: 2025-09-07 21:48:00

Author

adminitfy

Follow Me
Other Articles
Assam Government Fast-Tracks Reservation Certificates for Adivasi Communities
Previous

Assam Government Fast-Tracks Reservation Certificates for Adivasi Communities

Artificial Intelligence Firm Anthropic Hit with $1.5 Billion Copyright Ruling!
Next

Artificial Intelligence Firm Anthropic Hit with $1.5 Billion Copyright Ruling!

No Comment! Be the first one.

Leave a Reply Cancel reply

You must be logged in to post a comment.

Search...

Recent Posts

  • Manipur: Kangpokpi Warns Against Local Liquor After Suspected Deaths
    Manipur: Kangpokpi Warns Against Local Liquor After Suspected Deaths
    by adminitfy
    November 21, 2026
  • Empowering Northeast India: CII’s CSR Connect Event Ignites Social Development
    by adminitfy
    July 3, 2024
  • Urgent Crisis: Northeast on High Alert as Death Toll Tragically Rises in Assam
    by adminitfy
    July 3, 2024
  • Triumphant Breakthrough: Security Forces Successfully Capture 4 Insurgents in Manipur Operation
    by adminitfy
    July 3, 2024

Welcome to the ultimate source for fresh perspectives! Explore curated content to enlighten, entertain and engage global readers.

  • Facebook
  • X
  • Instagram
  • LinkedIn

Latest Posts

  • Manipur: Kangpokpi Warns Against Local Liquor After Suspected Deaths
  • Scrub Typhus Kills 68-Year-Old Man in Assam’s Bongaigaon
  • The Offshore Gaming Arbitrage: Why Bans Without Architecture Fail
  • Guwahati Waterbodies to Be Mapped Under Assam’s New Conservation Act
  • Animesh Debbarma Cabinet Rumours Dismissed: No Reshuffle
  • November 2026 (666)
  • October 2026 (646)
  • September 2026 (524)
  • August 2026 (1001)
  • July 2026 (986)
  • June 2026 (963)
  • May 2026 (922)
  • April 2026 (1525)
  • March 2026 (1522)
  • February 2026 (1252)
  • January 2026 (968)
  • December 2025 (942)
  • November 2025 (853)
  • October 2025 (869)
  • September 2025 (733)
  • August 2025 (810)
  • July 2025 (720)
  • June 2025 (1244)
  • May 2025 (2201)
  • April 2025 (1481)
  • March 2025 (2020)
  • February 2025 (1159)
  • January 2025 (1440)
  • December 2024 (1499)
  • November 2024 (1771)
  • October 2024 (1815)
  • September 2024 (1750)
  • August 2024 (1458)
  • July 2024 (1268)

Contact

Email

info@itfy.in

Location

INDIA

Copyright 2026 — Itfy.in. All rights reserved.